tiprankstipranks
Trending News
More News >
Mannatech Inc. (MTEX)
NASDAQ:MTEX
US Market
Advertisement

Mannatech (MTEX) AI Stock Analysis

Compare
69 Followers

Top Page

MTEX

Mannatech

(NASDAQ:MTEX)

Rating:49Neutral
Price Target:
$9.00
▼(-1.10% Downside)
Mannatech's overall stock score is primarily impacted by its financial performance challenges, including declining revenues and profitability issues. Technical analysis shows mixed signals with short-term bullish momentum but longer-term bearish trends. Valuation concerns are significant due to a negative P/E ratio and lack of dividend yield. Recent executive changes add uncertainty to the company's strategic direction.

Mannatech (MTEX) vs. SPDR S&P 500 ETF (SPY)

Mannatech Business Overview & Revenue Model

Company DescriptionMannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
How the Company Makes MoneyMannatech generates revenue primarily through the sale of its health and wellness products, which include dietary supplements and personal care items. The company's direct selling model allows it to recruit independent associates who earn commissions on product sales, creating a multi-level marketing structure. This model not only drives product sales but also encourages associates to build their own networks, thereby increasing overall sales volume. Additionally, Mannatech may generate income through strategic partnerships and collaborations, enhancing product offerings and expanding market reach. The company also benefits from customer loyalty programs and repeat purchases from existing customers, which contribute to a stable revenue flow.

Mannatech Financial Statement Overview

Summary
Mannatech faces significant financial challenges with declining revenues and profitability issues. The balance sheet shows moderate leverage, but negative returns on equity are concerning. Cash flow improvements are noted, but the company needs to address operational inefficiencies to enhance financial health.
Income Statement
45
Neutral
Mannatech's income statement shows declining revenue with a negative revenue growth rate of -1.79% TTM. The gross profit margin remains relatively strong at 75.79%, but the company is experiencing negative net profit margins, indicating losses. EBIT and EBITDA margins are also weak, reflecting operational challenges.
Balance Sheet
55
Neutral
The balance sheet shows a moderate debt-to-equity ratio of 0.84, suggesting manageable leverage. However, the return on equity is negative, indicating inefficiencies in generating returns for shareholders. The equity ratio is not provided, limiting further analysis.
Cash Flow
40
Negative
Cash flow analysis reveals negative operating cash flow and free cash flow, although there is a significant improvement in free cash flow growth. The operating cash flow to net income ratio is negative, highlighting cash flow challenges. The free cash flow to net income ratio is relatively high, indicating some efficiency in converting income to cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue112.97M117.87M131.96M137.21M159.76M151.41M
Gross Profit84.92M91.46M102.86M104.15M125.61M115.90M
EBITDA-764.00K5.55M702.00K1.26M10.85M6.52M
Net Income-3.91M2.49M-2.24M-4.49M9.84M6.26M
Balance Sheet
Total Assets32.78M36.06M41.21M49.13M59.63M65.34M
Cash, Cash Equivalents and Short-Term Investments6.08M11.40M7.73M13.78M24.18M22.21M
Total Debt6.37M6.69M5.73M6.17M6.13M8.95M
Total Liabilities26.82M27.44M30.72M34.95M35.21M39.36M
Stockholders Equity5.96M8.61M10.48M14.18M24.41M25.97M
Cash Flow
Free Cash Flow-1.78M1.96M-3.12M-3.66M10.12M5.08M
Operating Cash Flow-2.03M2.26M-2.37M-2.60M10.77M6.03M
Investing Cash Flow-773.00K-285.00K-747.00K-1.06M-650.00K-947.00K
Financing Cash Flow-1.39M1.96M-1.90M-4.33M-9.29M-9.92M

Mannatech Technical Analysis

Technical Analysis Sentiment
Positive
Last Price9.10
Price Trends
50DMA
8.68
Positive
100DMA
9.37
Negative
200DMA
10.09
Negative
Market Momentum
MACD
0.06
Negative
RSI
54.19
Neutral
STOCH
61.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTEX, the sentiment is Positive. The current price of 9.1 is above the 20-day moving average (MA) of 8.61, above the 50-day MA of 8.68, and below the 200-day MA of 10.09, indicating a neutral trend. The MACD of 0.06 indicates Negative momentum. The RSI at 54.19 is Neutral, neither overbought nor oversold. The STOCH value of 61.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MTEX.

Mannatech Risk Analysis

Mannatech disclosed 39 risk factors in its most recent earnings report. Mannatech reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Mannatech Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$37.61M14.7121.68%7.47%-11.81%-21.23%
63
Neutral
$20.42B14.38-2.77%3.17%2.07%-6.17%
60
Neutral
$257.46M-26.54%-15.33%75.52%
57
Neutral
$2.73M1.82-1.68%-9.25%-109.49%
53
Neutral
$14.94M2.3916.79%7.75%-21.61%
49
Neutral
$17.45M8.92-55.19%-7.69%-220.31%
48
Neutral
$62.75M-197.15%-18.44%37.92%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MTEX
Mannatech
9.10
1.55
20.53%
UG
United-Guardian
8.03
-5.42
-40.30%
TANH
Tantech Holdings
2.07
-3.39
-62.09%
SKIN
Beauty Health
2.04
0.25
13.97%
GROV
Grove Collaborative Holdings
1.56
0.27
20.93%
TKLF
Yoshitsu Co. Ltd. Sponsored ADR
3.53
-2.52
-41.65%

Mannatech Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Mannatech COO Resignation Announced
Negative
Jul 24, 2025

On July 21, 2025, Mannatech, Incorporated announced that its Chief Operating Officer, Peter Griscom, has resigned, effective August 8, 2025. This resignation may impact the company’s operations and strategic direction as they transition leadership roles.

Executive/Board ChangesBusiness Operations and Strategy
Mannatech Promotes Peter Griscom to COO Role
Positive
Jun 26, 2025

On June 26, 2025, Mannatech announced the promotion of Peter Griscom to Chief Operating Officer, effective July 1, 2025. Griscom, who has extensive experience in the consumer goods space and direct selling channel, previously served as the senior vice president of global operations. His promotion is expected to enhance operational efficiencies and streamline processes, positively impacting the company’s future.

Executive/Board ChangesShareholder Meetings
Mannatech Approves Proposals at Annual Shareholders’ Meeting
Neutral
Jun 4, 2025

On June 3, 2025, Mannatech, Incorporated held its annual shareholders’ meeting where all proposals were approved by the shareholders. The meeting saw the election of J. Stanley Fredrick and Tyler J. Rameson as Class II directors, the ratification of BDO USA, P.C. as the independent public accounting firm, and advisory approvals on executive compensation and its voting frequency. Approximately 77.8% of the total shares were represented at the meeting, indicating strong shareholder engagement.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 27, 2025